DTL Rekombinanter Antikörper
DTL Rekombinant Antikörper für IF/ICC, FC (Intra), Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
IF/ICC, FC (Intra), Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
230144C9
Kat-Nr. : 83107-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
83107-1-PBS bindet in IF/ICC, FC (Intra), Indirect ELISA DTL und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | DTL fusion protein Ag33391 |
| Vollständiger Name | denticleless homolog (Drosophila) |
| Berechnetes Molekulargewicht | 730 aa, 79 kDa |
| GenBank-Zugangsnummer | BC033540 |
| Gene symbol | DTL |
| Gene ID (NCBI) | 51514 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
CDT2, also named as L2DTL or RAMP, is one of the substrate receptors of the Cullin Ring Ubiquitin Ligase 4 that targets for ubiquitin mediated degradation a number of substrates, such as CDT1, p21 and CHK1, involved in the regulation of cell cycle and survival. CDT2 overexpression was reported in breast (PMID: 18542055), gastric (PMID: 19672268) and ovarian carcinomas (PMID: 23995842) and rhabdomyosarcomas (PMID: 19235922) and associated with the aggressiveness of hepatocellular carcinomas (PMID: 17106265).



